International Cannabis Weekly: 343

SWISS CITIZENS WITH ACCESS TO LEGAL ADULT-USE CANNABIS SOON TO TOP 15,000

The Department of Health for Basel-Stadt, which launched Switzerland’s first pilot trial last year, has published the interim results for its landmark adult-use pilot study.

READ MORE  »

CANADIAN CANNABIS STOCKS RALLY AS INDUSTRY VETERAN APPOINTED TO LOBBY GROUP

READ MORE »

AUSTRIA TIGHTENS POLICE CONTROLS WITH GERMANY AFTER CANG BILL APPROVAL

READ MORE »

• CSU in Germany wants to monitor cannabis consumption by analysing wastewater samples.
• Germany’s recent legislative overhaul marks a significant turning point for the European cannabis landscape.
• Flora Growth Corp. enters into binding Letter of Intent to acquire Germany-based TruHC pharma GmbH.
• Online medical cannabis clinic, Treat It, announces expansion to include specialised psychiatric services.
• Hemp will play role in UK housing development that aims for ‘exponential sustainability’.
• A French cooperative has opened a hemp fibre processing facility in the fight against fast fashion.

READ STOCKS REPORT »

• Florida voters to decide on cannabis legalisation in November despite attorney general’s objection.
• Cash-strapped cannabis operators surpassed US$3.8 billion in delinquent payments in 2023.
• Canopy Growth gains Institutional Shareholder Services support for vote on U.S. cannabis market entry.
• Hawaii cannabis advocates push for legalisation ahead of deadline for critical bill.
• Minnesota opens applications for hemp grower-processor licences, with the application deadline of 30 April.
• Crime concerns stall Kansas medical marijuana proposal until next year’s legislative session.

FREE EXEC SUMMARY »

• From pioneer to global supplier: Canada has played a crucial role in global cannabis industry expansion.
• Avicanna releases 2023 audited financial results, showing a 314% revenue growth last year compared to 2022.
• Tilray Brands is set to announce its third quarter 2024 financial results on April 9, 2024.
• Cannabis operator Indiva considers potential sale among other strategic options.
• Imperial Brands has converted more than CA$123 million in debt to Auxly Cannabis shares.
• IM Cannabis enters Canadian adult-use market with launch of premium WAGNERS brand.

• Colombia’s medical cannabis exports continued to grow last year, but fell short of operators’ expectations.
• Argentina’s National Seed Institute (INASE) has announced the temporary suspension of new operator registrations.
• National Health Surveillance Agency (Anvisa) in Brazil proposes cannabis flowers for the Brazilian pharmacopoeia.
• Medical Marijuana Inc. secures Alzheimer’s approval for its full-spectrum CBD oil in Brazil.

• MGC Pharma officially changes its name to Argent BioPharma after shareholder approval.
• The number of SAS-B approvals for medicinal cannabis in Australia surged again in March, with 14,791 approvals.
• Rua Bioscience signs agreement with AlphaPharma for the supply of medical cannabis flower to Germany.
• Althea announces the completion of a staff restructure, which will save the company AU$1.5 million per year.

• Malawian legislators have legalised the cultivation of a potent local variety of cannabis for industrial and medical use.
• BOL Pharma applies to court to freeze all proceedings against it after reaching a state of insolvency due to debts.